Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS): the Effects of D2 Antagonism on Candidate Endophenotypes

NCT01154829 is registered in ClinicalTrials.gov with University of Copenhagen as lead sponsor.

NCT NCT01154829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01154829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS): the Effects of D2 Antagonism on Candidate Endophenotypes
Lead sponsor
University of Copenhagen
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2008
Completion date
May 31, 2016
Enrollment
136 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia